Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

IMIQUIMOD

IMIQUIMOD

Standard Dose
3.75%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IMIQUIMOD is listed in Drugs@FDA under application 205971 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IMIQUIMOD Form and strength CREAM;TOPICAL - 3.75% Sponsor TARO Submission history Latest submission status date: 2025-09-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview IMIQUIMOD is listed in Drugs@FDA under application 205971 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IMIQUIMOD Form and strength CREAM;TOPICAL - 3.75% Sponsor TARO Submission history Latest submission status date: 2025-09-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.